Phase IV Clinical Trial to Evaluate in Children with Symptom Contral due to Persistent Allergic Rhinitis
Not Applicable
Terminated
- Conditions
- Diseases of th respiratory system
- Registration Number
- KCT0000972
- Lead Sponsor
- Dong Hwa Pharm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Persistent Nasal symptom for more than 4 days and 4 weeks per week or more , and the duration and specificity of immunoglobulin-positive test results identified children with persistent allergic rhinitis
2. Randomized at baseline TNSS score of the previous three days more than the average of 3 points
3. Subjects and subjects representative(guardian) to participate in this clinical trial voluntarily provided written informed consent, and if consent
Exclusion Criteria
1. Within 2 weeks before screening Otolaryngology ever experienced patients infected
2. Steroid therapy, and patients with asthma who need
3. During clinical trials, systemic steroids or antihistamines necessary medical treatment and patients with the skin disease
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in TNSS(Total Nasal Symptom Score)
- Secondary Outcome Measures
Name Time Method Change in TNSS(Total Nasal Symptom Score);Change in TFSS(Total Four Symptom Score)